Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease

Journal of Oral and Maxillofacial Surgery

Volumn 56, Issue 2, 1998, Pages 192-198

  Kubota, Eiro ^a   Kubota, Takao ^d   Matsumoto, Jun ^a   Shibata, Takanori ^b   Murakami, Ken Ichiro ^c  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PROTEINASE;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; DRUG SYNOVIAL FLUID LEVEL; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MALE; PROTEIN DEGRADATION; SYNOVIOCYTE; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0031951640     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(98)90868-0     Document Type: Article

References (29)

1. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305, 1990
2. Hasty KA, Reife RA, Karg AH, et al: The role of stromelysin in cartilage destruction hat accompanies in inflammatory arthritis. Arthritis Rheum 33:388, 1990
3. Hutchinson NI, Lark MW, MacNaul KL, et al: In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1β. Arthritis Rheum 35:1227, 1992
4. Firestein GS, Paine MM: Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 140:1309, 1992
5. Brinkerhoff CE: Joint destruction in arthritis: Metalloproteinase in the spotlight. Arthritis Rheum 34:1073, 1991
6. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151, 1995
7. Holt I, Cooper RG, Denton J, et al: Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol 31:725, 1992
8. Shafer DM, Assael L, White LB, et al: Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 52:786, 1994
9. Fu K, Ma X, Zhang Z, et al: Tumor necrosis factor in synovial fluid of patients with temporomaudibular disorders. J Oral Maxillofac Surg 53:424, 1995
10. Kubota E, Imamura H, Kubota T, et al: Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20, 1997
11. Smith AJ, Basu MK, Speculand B, et al: Synovial fluid glycosaminoglycan (acid mucopolysaccharide) analysis in assessment of temporomandibular joint dysfunction. A pilot study. Br Oral Maxillofac Surg 27:353, 1989
12. Israel HA: Synovial fluid analysis. Oral Maxillofac Clin North Am 1:85, 1989
13. Quinn JH: Pathogenesis of temporomandibular joint chondromalacia and arthralgia. Oral Maxillofac Surg Clin North Am 1:47, 1989
14. Bayliss MT, Ali Y: Studies on cathepsin B in human articular cartilage. Biochem J 171:149, 1978
15. Sapolsky AI, Altman RD, Woessner JF, et al: The action of cathepsin D in human cartilage on proteoglycans. J Clin Invest 52:624, 1973
16. Okada Y, Shinmei M, Tanaka O, et al: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680, 1992
17. Gruber BL, Sorbi D, French DL, et al: Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker. Clin Immunol Immunopathol 78:161, 1996
18. Nagase H, Woessner JF: Role of endogenous proteinases in the degradation of cartilage matrix, in Woessner JF, Howell DS (eds): Joint Cartilage Degradation. New York, NY, Marcel Dekker, 1992
19. American Association of Oral and Maxillofacial Surgeons: Position paper on temporomandibular joint arthroscopy, 1988
20. Overall CM, Wrana JL, Sodek J: Independent regulation of collagenase, 72-Kda progelatinase, and metalloendo proteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860, 1989
21. Kopp S, Wenneberg B, Clemensson E: Clinical, microscopical, and biochemical investigation of synovial fluid from temporomandibular joints. ScandJ Dent Res 91:33, 1983
22. Quinn JH, Bazan NG: Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg 48:968, 1990
23. Holmlund A, Ekblom A, Hansson P, et al: Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint: A correlation with symptoms, signs and arthroscopic findings. Int J Oral Maxillofac Surg 20:228, 1991
24. Kubota T, Matsumoto A, Watanabe T, et al: Matrix metalloproteinases (MMPs) in synovial fluid as markers for cartilage degradation in temporomandibular joint. Oral Surg Oral Med Oral Pathol (submitted for publication)
25. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEBJ 5:2145, 1991
26. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinase, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36:181, 1993
27. Fessler LI, Duncan KG, Fessler JH, et al: Characterization of procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 259:9783, 1984
28. Brenner CA, Adler RR, Rappelee DA, et al: Genes for extracellular matrix-degrading metalloproteinase and their inhibitor, TIMP are expressed during early mammalian development. Genes Dev 3:848, 1989
29. Reponen P, Sahlberg C, Munant C, et al: High expression of 92 KDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 267:7856, 1994